+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

Gabapentin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gabapentin Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
Obsessive Compulsive Disorder Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Obsessive Compulsive Disorder Treatment Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Anxiety and Depression Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Anxiety and Depression Treatment Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Alprazolam Powder Market Report and Forecast 2023-2031 - Product Thumbnail Image

Alprazolam Powder Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Schizophrenia Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Schizophrenia Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Behavioural Health Market Report and Forecast 2023-2031 - Product Thumbnail Image

Behavioural Health Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 160 Pages
  • Global
From
Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Adderall Drug Market Report and Forecast 2023-2031 - Product Thumbnail Image

Adderall Drug Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Bipolar Disorder Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Bipolar Disorder Treatment Market Report and Forecast 2023-2031

  • Report
  • March 2023
  • 147 Pages
  • Global
From
Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region - Product Thumbnail Image

Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Antipsychotic Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Therapeutic Class; By Application; By Distribution Channel; and By Region - Product Thumbnail Image

Antipsychotic Drugs Market Analysis & Forecast 2024-2034: Market By Drug; By Therapeutic Class; By Application; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Clinical Trials: Psychedelic Therapeutics - Product Thumbnail Image

Clinical Trials: Psychedelic Therapeutics

  • Report
  • July 2024
  • 32 Pages
  • Global
From
Psychedelics Therapeutics Development and Trends, 2024 - Product Thumbnail Image

Psychedelics Therapeutics Development and Trends, 2024

  • Report
  • April 2024
  • 36 Pages
  • Global
From
Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Post-Traumatic Stress Disorder (PTSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2023
  • 76 Pages
  • Global
From
Schizophrenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Thumbnail Image

Schizophrenia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • June 2023
  • 2047 Pages
  • Global
From
Body Dysmorphic Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Body Dysmorphic Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • April 2023
  • 53 Pages
  • Global
From
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • March 2023
  • 68 Pages
  • Global
From
Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Treatment Resistant Depression Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • October 2022
  • 292 Pages
  • Global
From
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • September 2022
  • 129 Pages
  • Global
From
Schizophrenia Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Schizophrenia Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • July 2022
  • 33 Pages
  • Global
From
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more